← Eichor
Study identifier: NCT07579845 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Clinical Trial Evaluating the Impact of a Dietary Supplement Containing Humic and Fulvic Acid on Epigenetic Markers of Biological Age, Detoxification, Inflammation, and Oxidative Stress

Condition: Detoxification · Inflammation · Biological Aging  ·  Sponsor: OvationLab

PhaseNA
Planned participants60
Who can joinAll sexes, 40 Years to no upper limit
Healthy volunteersYes

About this study

The primary purpose of this study is to evaluate the impact of BioToxin Binder, a commercially available dietary supplement containing humic and fulvic acid, on markers of biologic age, detoxification, inflammation, oxidative stress, and related markers among generally healthy adults.

This description comes directly from the study's public registry record.

Talk to the study team

Study Administrator  ·  (240) 232-2103  ·  info@ovationlab.com

Always discuss trial participation with your own doctor first.

Locations (1)

OvationLabRichmond, Virginia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07579845